Alteration of cell cycle in cervical tumor associated with human papillomavirus - Cyclin-dependent kinase inhibitors

Namhoon Cho, YoungTae Kim, Jae Wook Kim

Research output: Contribution to journalReview article

41 Citations (Scopus)

Abstract

The ability of viral oncoproteins to subvert cell cycle checkpoints may constitute a mechanism by which viral oncoproteins induce genetic instability. HPV 16 E6 and E7 disrupt cell cycle checkpoints, particularly affecting nearly all cyclin-dependent kinase inhibitors linked to the G1- and G2-checkpoints, in each case by means of a different mechanism. HPV 16 E7 shows homology with the pRb binding sites of cyclin D1, which consequently releases E2F. In addition, E7 directly binds to p21, and releases PCNA and other S-phase promoting genes. In turn, released E2F activates cyclin E, and cyclin E accelerates p27 proteolysis as a function of the antagonistic reaction of its own inhibitor. The induction of p16 expression is assumed to be indirectly associated with E7, which is upregulated only after prolonged inactivation of Rb. HPV 16 E6 decreased the fidelity of multiple checkpoints controlling both entry into and exit from mitosis, with the mechanism of p53 inactivation. In addition, HPV 16 E6 increased the sensitivity to chemically induced S-phase premature mitosis and decreased mitotic spindle assembly checkpoint function. Alongside the impressive advances made in the understanding of the molecular mechanisms, which HPV disrupts, the validity of these conclusions should be evaluated in the diagnostic and prognostic fields.

Original languageEnglish
Pages (from-to)722-728
Number of pages7
JournalYonsei Medical Journal
Volume43
Issue number6
DOIs
Publication statusPublished - 2002 Jan 1

Fingerprint

Human papillomavirus 16
Cyclin-Dependent Kinases
Cell Cycle
M Phase Cell Cycle Checkpoints
Cyclin E
Oncogene Proteins
Cell Cycle Checkpoints
S Phase
Mitosis
Neoplasms
Cyclin D1
Proliferating Cell Nuclear Antigen
Proteolysis
Binding Sites
Genes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{3db4ab9eb8f448dc8c3b358112cdaf10,
title = "Alteration of cell cycle in cervical tumor associated with human papillomavirus - Cyclin-dependent kinase inhibitors",
abstract = "The ability of viral oncoproteins to subvert cell cycle checkpoints may constitute a mechanism by which viral oncoproteins induce genetic instability. HPV 16 E6 and E7 disrupt cell cycle checkpoints, particularly affecting nearly all cyclin-dependent kinase inhibitors linked to the G1- and G2-checkpoints, in each case by means of a different mechanism. HPV 16 E7 shows homology with the pRb binding sites of cyclin D1, which consequently releases E2F. In addition, E7 directly binds to p21, and releases PCNA and other S-phase promoting genes. In turn, released E2F activates cyclin E, and cyclin E accelerates p27 proteolysis as a function of the antagonistic reaction of its own inhibitor. The induction of p16 expression is assumed to be indirectly associated with E7, which is upregulated only after prolonged inactivation of Rb. HPV 16 E6 decreased the fidelity of multiple checkpoints controlling both entry into and exit from mitosis, with the mechanism of p53 inactivation. In addition, HPV 16 E6 increased the sensitivity to chemically induced S-phase premature mitosis and decreased mitotic spindle assembly checkpoint function. Alongside the impressive advances made in the understanding of the molecular mechanisms, which HPV disrupts, the validity of these conclusions should be evaluated in the diagnostic and prognostic fields.",
author = "Namhoon Cho and YoungTae Kim and Kim, {Jae Wook}",
year = "2002",
month = "1",
day = "1",
doi = "10.3349/ymj.2002.43.6.722",
language = "English",
volume = "43",
pages = "722--728",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "6",

}

Alteration of cell cycle in cervical tumor associated with human papillomavirus - Cyclin-dependent kinase inhibitors. / Cho, Namhoon; Kim, YoungTae; Kim, Jae Wook.

In: Yonsei Medical Journal, Vol. 43, No. 6, 01.01.2002, p. 722-728.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Alteration of cell cycle in cervical tumor associated with human papillomavirus - Cyclin-dependent kinase inhibitors

AU - Cho, Namhoon

AU - Kim, YoungTae

AU - Kim, Jae Wook

PY - 2002/1/1

Y1 - 2002/1/1

N2 - The ability of viral oncoproteins to subvert cell cycle checkpoints may constitute a mechanism by which viral oncoproteins induce genetic instability. HPV 16 E6 and E7 disrupt cell cycle checkpoints, particularly affecting nearly all cyclin-dependent kinase inhibitors linked to the G1- and G2-checkpoints, in each case by means of a different mechanism. HPV 16 E7 shows homology with the pRb binding sites of cyclin D1, which consequently releases E2F. In addition, E7 directly binds to p21, and releases PCNA and other S-phase promoting genes. In turn, released E2F activates cyclin E, and cyclin E accelerates p27 proteolysis as a function of the antagonistic reaction of its own inhibitor. The induction of p16 expression is assumed to be indirectly associated with E7, which is upregulated only after prolonged inactivation of Rb. HPV 16 E6 decreased the fidelity of multiple checkpoints controlling both entry into and exit from mitosis, with the mechanism of p53 inactivation. In addition, HPV 16 E6 increased the sensitivity to chemically induced S-phase premature mitosis and decreased mitotic spindle assembly checkpoint function. Alongside the impressive advances made in the understanding of the molecular mechanisms, which HPV disrupts, the validity of these conclusions should be evaluated in the diagnostic and prognostic fields.

AB - The ability of viral oncoproteins to subvert cell cycle checkpoints may constitute a mechanism by which viral oncoproteins induce genetic instability. HPV 16 E6 and E7 disrupt cell cycle checkpoints, particularly affecting nearly all cyclin-dependent kinase inhibitors linked to the G1- and G2-checkpoints, in each case by means of a different mechanism. HPV 16 E7 shows homology with the pRb binding sites of cyclin D1, which consequently releases E2F. In addition, E7 directly binds to p21, and releases PCNA and other S-phase promoting genes. In turn, released E2F activates cyclin E, and cyclin E accelerates p27 proteolysis as a function of the antagonistic reaction of its own inhibitor. The induction of p16 expression is assumed to be indirectly associated with E7, which is upregulated only after prolonged inactivation of Rb. HPV 16 E6 decreased the fidelity of multiple checkpoints controlling both entry into and exit from mitosis, with the mechanism of p53 inactivation. In addition, HPV 16 E6 increased the sensitivity to chemically induced S-phase premature mitosis and decreased mitotic spindle assembly checkpoint function. Alongside the impressive advances made in the understanding of the molecular mechanisms, which HPV disrupts, the validity of these conclusions should be evaluated in the diagnostic and prognostic fields.

UR - http://www.scopus.com/inward/record.url?scp=0036957236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036957236&partnerID=8YFLogxK

U2 - 10.3349/ymj.2002.43.6.722

DO - 10.3349/ymj.2002.43.6.722

M3 - Review article

VL - 43

SP - 722

EP - 728

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 6

ER -